It was a daunting task to develop the first industry forum on thinking radically differently about the way we perform clinical trials, but the result was this conference. The event was launched in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.

The first DPHARM addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas. By the time the 2nd annual DPHARM program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them.

Fast forward to 2023, the 13th annual program will cover the full spectrum of clinical research, challenge how we can be radically more efficient in managing clinical operations, reduce patient, sites and physician burden to participate in research, and thrive through a digital transformation. DPHARM 2023 expects to attract over 750 attendees.

We will include both industry and out-of-industry keynotes. We will feature more than 20 pharma companies, who will report on specific innovations they’ve been working on over the past 12 months to better deliver medicines.

DPHARM 2023 will provide a wide choice of tracks including AI/machine learning, accelerating and scaling efficiencies, innovative approaches to reduce sites/patient burden, end-to-end digital transformation, operationalizing DCTs, and more. DPHARM underscores the promise and challenge of innovation in advancing drug development.